Combined effects of mild hypothermia and glycoprotein IIb/IIIa antagonists on platelet-platelet and leukocyte-platelet aggregation

American Journal of Cardiology

Volumn 92, Issue 9, 2003, Pages 1099-1101

  Frelinger III, Andrew L ^b   Furman, Mark I ^b   Barnard, Marc R ^b   Krueger, Lori A ^b   Dae, Michael W ^b   Michelson, Alan D ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; ADENOSINE DIPHOSPHATE; EPTIFIBATIDE; GLYCOPROTEIN IIB; GLYCOPROTEIN IIIA; PROTEIN INHIBITOR; TIROFIBAN;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; HUMAN; HUMAN CELL; HYPOTHERMIA; IN VITRO STUDY; INHIBITION KINETICS; LEUKOCYTE AGGREGATION; MALE; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION;

EID: 0142227266     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2003.06.007     Document Type: Article

References (14)

1. Dae M.W., Gao D.W., Sessler D.I., Chair K., Stillson C.A. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs. Am J Physiol. 282:2002;H1584-H1591.
2. Schwartz L.M., Verbinski S.G., Vander Heide R.S., Reimer K.A. Epicardial temperature is a major predictor of myocardial infarct size in dogs. J Mol Cell Cardiol. 29:1997;1577-1583.
3. Hale S.L., Dave R.H., Kloner R.A. Regional hypothermia reduces myocardial necrosis even when instituted after the onset of ischemia. Basic Res Cardiol. 92:1997;351-357.
4. Miki T., Liu G.S., Cohen M.V., Downey J.M. Mild hypothermia reduces infarct size in the beating rabbit heart a practical intervention for acute myocardial infarction? Basic Res Cardiol. 93:1998;372-383.
5. Dixon S.R., Whitbourn R.J., Dae M.W., Grube E., Sherman W., Schaer G.L., Jenkins J.S., Baim D.S., Gibbons R.J., Kuntz R.E., et al. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction. J Am Coll Cardiol. 40:2002;1928-1934.
6. Popma J.J., Ohman E.M., Weitz J., Lincoff A.M., Harrington R.A., Berger P. Antithrombotic therapy in patients undergoing percutaneous coronary intervention. Chest. 119:(suppl):2001;321S-336S.
7. Michelson A.D., MacGregor H., Barnard M.R., Kestin A.S., Rohrer M.J., Valeri C.R. Reversible inhibition of human platelet activation by hypothermia in vivo and in vitro. Thromb Haemost. 71:1994;633-640.
8. Michelson A.D., Barnard M.R., Khuri S.F., Rohrer M.J., MacGregor H., Valeri C.R. The effects of aspirin and hypothermia on platelet function in vivo. Br J Haematol. 104:1999;64-68.
9. Suzuki Y., Hillyer P., Miyamoto S., Niewiarowski S., Sun L., Rao A.K., Hollenbach S., Edmunds L.H. Jr. Integrilin prevents prolonged bleeding times after cardiopulmonary bypass. Ann Thorac Surg. 66:1998;373-381.
10. Valeri C.R., Cassidy G., Khuri S., Feingold H., Ragno G., Altschule M.D. Hypothermia-induced reversible platelet dysfunction. Ann Surg. 205:1987;175-181.
11. Coller B.S. Platelet GPIIb/IIIa antagonists the first anti-integrin receptor therapeutics. J Clin Invest. 99:1997;1467-1471.
12. Nurden P., Poujol C., Durrieu-Jais C., Winckler J., Combrie R., Macchi L., Bihour C., Wagner C., Jordan R., Nurden A.T. Labeling of the internal pool of GP IIb-IIIa in platelets by c7E3 Fab fragments (abciximab) flow and endocytic mechanisms contribute to the transport. Blood. 93:1999;1622-1633.
13. Coller B.S. Monitoring platelet GP IIb/IIIa antagonist therapy. Circulation. 96:1997;3828-3832.
14. Steinhubl S.R., Talley J.D., Braden G.A., Tcheng J.E., Casterella P.J., Moliterno D.J., Navetta F.I., Berger P.B., Popma J.J., Dangas G., et al. Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention results of the GOLD (AU-Assessing Ultegra) multicenter study. Circulation. 103:2001;2572-2578.